Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CELF2 antisense RNA 1 (CELF2-AS1) is a long non-coding RNA (lncRNA) gene located on chromosome 10 (official symbol: CELF2-AS1, HGNC:23515, NCBI Gene ID: 414196). It acts as an antisense RNA overlapping the CELF2 gene, and is classified as an lncRNA rather than a traditional protein-coding gene or therapeutic target. According to genomic databases, it is predicted to be located in the extracellular region[4][7][8]. CELF2-AS1 has been linked via database annotation to "Developmental and epileptic encephalopathy 97"[7], but there is currently no strong evidence for direct disease causation or validated drug targeting. The biological function remains largely uncharacterized, though as an antisense lncRNA it is presumed to play a regulatory role in gene expression, possibly modulating the expression of the CELF2 gene or neighboring loci[6][7]. No approved drugs, clinical biomarkers, or therapeutics specifically interact with CELF2-AS1. Its status as a therapeutic target is not established, and the protein-coding potential is either absent or not demonstrated[6][7][8]. Summary: CELF2-AS1 is a long non-coding antisense RNA gene, not a canonical drug target or protein. Its function is not well-defined, but it is classified among regulatory lncRNAs that may influence gene expression. No interacting drugs, mechanisms of action, or clinical safety concerns are currently described.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CELF2 antisense RNA 1 (CELF2-AS1).